Impact of the COVID-19 pandemic on breast cancer referrals and diagnoses in 2020 and 2021: a population-based study in England
Br J Surg
.
2022 Feb 1;109(2):e29-e30.
doi: 10.1093/bjs/znab426.
Authors
Toral Gathani
1
2
,
Gillian Reeves
1
,
David Dodwell
2
3
,
Kieran Horgan
4
,
Olive Kearins
5
,
Sau Wan Kan
1
,
Sian Sweetland
1
Affiliations
1
Cancer Epidemiology Unit, Nuffield Department of Population Health, Oxford, UK.
2
Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
3
Clinical Trials Service Unit, Nuffield Department of Population Health, Oxford, UK.
4
Department of Breast Surgery, St James' Hospital, Leeds, UK.
5
Breast Cancer Screening Programme, Screening Division, Public Health England, Birmingham, UK.
PMID:
34904165
PMCID:
PMC8807144
DOI:
10.1093/bjs/znab426
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Breast Neoplasms / epidemiology*
COVID-19
Datasets as Topic
England / epidemiology
Female
Humans
Pandemics*
Referral and Consultation / statistics & numerical data*
Grants and funding
G0700474/MRC_/Medical Research Council/United Kingdom
C16077/A29186/CRUK_/Cancer Research UK/United Kingdom
29186/CRUK_/Cancer Research UK/United Kingdom
C8225/A21133/CRUK_/Cancer Research UK/United Kingdom
21133/CRUK_/Cancer Research UK/United Kingdom
16491/CRUK_/Cancer Research UK/United Kingdom
MR/K02700X/1/MRC_/Medical Research Council/United Kingdom
MC_U137686858/MRC_/Medical Research Council/United Kingdom
G9900923/MRC_/Medical Research Council/United Kingdom